A probability-based approach for predicting HIV infection in a low prevalent population of injection drug users

Annals of Epidemiology

Volumn 7, Issue 1, 1997, Pages 28-34

  Cheng, Fenny K ^a   Ford, Wesley L ^a   Weber, Mark D ^a   Cheng, Shiu Yuen ^b   Kerndt, Peter R ^a  

^a LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; IDU risk behaviors; IDU risk score; IDUs; low HIV seroprevalence; probability model

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SELF REPORT; UNITED STATES;

ADULT; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HUMANS; LOGISTIC MODELS; MALE; MODELS, STATISTICAL; NEEDLE SHARING; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0031049182     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00108-1     Document Type: Article

References (12)

1. 1. Ford WL, Melia N, Weber MD, et al. HIV-1 Seroincidence Rates and Trends in Select Populations in Los Angeles County, 1988-1991. Los Angeles: Los Angeles County Department of Health Services; 1992.
2. 2. Siegal HA, Carlson RG, Falck R, et al. HIV infection and risk behaviors among intravenous drug users in low seroprevalence areas in the midwest. Am J Public Health. 1991;81:1642-1644.
3. 3. Allard R. A mathematical model to describe the risk of infection from sharing injection equipment. J Acquir Immune Defic Syndr. 1990;3:1010-1016.
4. 4. Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human ummunodeficiency virus type 1 (HIV-1) associated with clinical exposures: A prospective evaluation. Ann Inter Med. 1990;13:740-746.
5. 5. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987;1:39-44.
6. 6. Chaisson RE, Bacchetti P, Osmond D, et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261:561-565.
7. 7. Schoenbaumm EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-879.
8. 8. Battjes RJ, Pickens RW, Amsel Z. Introduction of HIV infection among intravenous drug abusers in low prevalence areas. J Acquir Immune Defic Syndr. 1989;2:533-539.
9. 9. Chandrasekar PH, Molinari JA, Kruse JA. Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low prevalence area. South Med J. 1990;83:996-1001.
10. 10. Wendt D, Sadowski L, Markowitz N, Saravolatz. Prevalence of serum antibody to human immunodeficiency virus among hospitalized intravenous drug abusers in a low-risk geographic area. J Infect Dis. 1987;155:151-152.
11. 11. Williams ML. HIV seroprevalence among IVDUs in Houston, Texas. Am J Public Health. 1990;80:1507-1509.
12. 12. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 1995;142:864-874.